Logically, most longs probably believe the trial has already started since Leo's last P.R. stated that the trial would start last week.
The need for a PR on this topic is only necessary if the trial DID NOT start last week.
If shareholders are in the dark, so too are individuals, groups and organizations who have a vested interest in IPIX's demise.
I'm ecstatic that Leo is focused on B-COVID development and not the whims of penny flippers who want to see IPIX at .50.
Except for regulatory requirements, I think Leo, if he can, shouldn't issue any PRs until this trial is over, irrespective of where the stock price goes.
Yes in some cases uncertainty is good. I am not certain shit taste bad, but logically, I believe it does, and I choose to go to my grave with this uncertainty.
Yes well I believe the trial has started and we are in the recruitment phase. Dosing will start with patients consents or a doctor recommendation for those worse off and on ventilators.
And not only did the trial probably start, IP probably got the grant too, to study other viruses. We never heard otherwise, right? And why should Leo tell anybody- keep the doubters on their toes!
Maybe he started B OM 3 and B UC oral trials too.
But he just is not saying because IP is so crazy like a fox.
I agree- run the company and move it forward and never tell anyone about it. Until you finally do tell someone.
Really, there wasn't much uncertainty the past 5 years issuing PR after PR for P/OM/UP and now CV19. Now, he's going to stump the world and hold back important info about dosing first patient... He'll surely trick those naked shorts... The facts are clear, dosing has yet to start or we'd see a PR... He's done so the previous trials...